News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Fresh From IPO, Five Prime Therapeutics, Inc. (FPRX) Advances Arthritis And Cancer Drugs


12/19/2013 7:14:41 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Investors in healthcare’s big IPO class of 2013 have seen some wild swings in share values since the debuts of dozens of new public companies. Hot trading in the Cambridge, MA-based companies Foundation Medicine and Epizyme pushed their peak prices above $40 for a time, followed by declines that sent the stocks swooning below their initial closing prices. Redwood City-based Relypsa’s shares roughly doubled in value in less than a month.

Help employers find you! Check out all the jobs and post your resume.

Read at Xconomy

comments powered by Disqus
Xconomy
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES